世界の肝不全治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Liver Failure Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3456 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、肝不全治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フェニル酢酸オルニチン、MTL-CEBPA、F-573、BL-1220、PP-100、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肝不全治療の市場動向 ・企業の競争状況、市場シェア ・肝不全治療の種類別市場規模（フェニル酢酸オルニチン、MTL-CEBPA、F-573、BL-1220、PP-100、その他） ・肝不全治療の用途別市場規模（クリニック、病院、その他） ・肝不全治療の北米市場規模2016-2027（アメリカ、カナダ） ・肝不全治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肝不全治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肝不全治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・肝不全治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alfact Innovation、BioLineRx Ltd、Cell2B Advanced Therapeutics SA、Conatus Pharmaceuticals Inc、Immune Pharmaceuticals Inc、Mina Therapeutics Ltd、Mylan NV、Ocera Therapeutics Inc、PledPharma AB、Promethera Biosciences SA、Silence Therapeutics Plc、Unicyte AG、Ventria Bioscience、Vital Therapies Inc） ・結論

Market Analysis and Insights: Global Liver Failure Therapeutics Market
The global Liver Failure Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liver Failure Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liver Failure Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liver Failure Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liver Failure Therapeutics market.

Global Liver Failure Therapeutics Scope and Market Size
Liver Failure Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ornithine Phenylacetate
MTL-CEBPA
F-573
BL-1220
PP-100
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma AB
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Unicyte AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ornithine Phenylacetate
1.2.3 MTL-CEBPA
1.2.4 F-573
1.2.5 BL-1220
1.2.6 PP-100
1.2.7 Others
1.3 Market by Application
1.3.1 Global Liver Failure Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Liver Failure Therapeutics Market Perspective (2016-2027)
2.2 Liver Failure Therapeutics Growth Trends by Regions
2.2.1 Liver Failure Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liver Failure Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Liver Failure Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Liver Failure Therapeutics Industry Dynamic
2.3.1 Liver Failure Therapeutics Market Trends
2.3.2 Liver Failure Therapeutics Market Drivers
2.3.3 Liver Failure Therapeutics Market Challenges
2.3.4 Liver Failure Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Liver Failure Therapeutics Players by Revenue
3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liver Failure Therapeutics Revenue
3.4 Global Liver Failure Therapeutics Market Concentration Ratio
3.4.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2020
3.5 Liver Failure Therapeutics Key Players Head office and Area Served
3.6 Key Players Liver Failure Therapeutics Product Solution and Service
3.7 Date of Enter into Liver Failure Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Failure Therapeutics Breakdown Data by Type
4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2022-2027)

5 Liver Failure Therapeutics Breakdown Data by Application
5.1 Global Liver Failure Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Liver Failure Therapeutics Market Size (2016-2027)
6.2 North America Liver Failure Therapeutics Market Size by Type
6.2.1 North America Liver Failure Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Liver Failure Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Liver Failure Therapeutics Market Size by Type (2016-2027)
6.3 North America Liver Failure Therapeutics Market Size by Application
6.3.1 North America Liver Failure Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Liver Failure Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Liver Failure Therapeutics Market Size by Application (2016-2027)
6.4 North America Liver Failure Therapeutics Market Size by Country
6.4.1 North America Liver Failure Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Liver Failure Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Liver Failure Therapeutics Market Size (2016-2027)
7.2 Europe Liver Failure Therapeutics Market Size by Type
7.2.1 Europe Liver Failure Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Liver Failure Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Liver Failure Therapeutics Market Size by Type (2016-2027)
7.3 Europe Liver Failure Therapeutics Market Size by Application
7.3.1 Europe Liver Failure Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Liver Failure Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Liver Failure Therapeutics Market Size by Application (2016-2027)
7.4 Europe Liver Failure Therapeutics Market Size by Country
7.4.1 Europe Liver Failure Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Liver Failure Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Liver Failure Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Liver Failure Therapeutics Market Size by Type
8.2.1 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Application
8.3.1 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Liver Failure Therapeutics Market Size by Region
8.4.1 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Liver Failure Therapeutics Market Size (2016-2027)
9.2 Latin America Liver Failure Therapeutics Market Size by Type
9.2.1 Latin America Liver Failure Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Liver Failure Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Liver Failure Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Liver Failure Therapeutics Market Size by Application
9.3.1 Latin America Liver Failure Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Liver Failure Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Liver Failure Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Liver Failure Therapeutics Market Size by Country
9.4.1 Latin America Liver Failure Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Liver Failure Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Liver Failure Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type
10.2.1 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Application
10.3.1 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Liver Failure Therapeutics Market Size by Country
10.4.1 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Company Details
11.1.2 Alfact Innovation Business Overview
11.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
11.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2016-2021)
11.1.5 Alfact Innovation Recent Development
11.2 BioLineRx Ltd
11.2.1 BioLineRx Ltd Company Details
11.2.2 BioLineRx Ltd Business Overview
11.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
11.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2016-2021)
11.2.5 BioLineRx Ltd Recent Development
11.3 Cell2B Advanced Therapeutics SA
11.3.1 Cell2B Advanced Therapeutics SA Company Details
11.3.2 Cell2B Advanced Therapeutics SA Business Overview
11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
11.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2016-2021)
11.3.5 Cell2B Advanced Therapeutics SA Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Details
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 Immune Pharmaceuticals Inc
11.5.1 Immune Pharmaceuticals Inc Company Details
11.5.2 Immune Pharmaceuticals Inc Business Overview
11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.5.5 Immune Pharmaceuticals Inc Recent Development
11.6 Mina Therapeutics Ltd
11.6.1 Mina Therapeutics Ltd Company Details
11.6.2 Mina Therapeutics Ltd Business Overview
11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
11.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2016-2021)
11.6.5 Mina Therapeutics Ltd Recent Development
11.7 Mylan NV
11.7.1 Mylan NV Company Details
11.7.2 Mylan NV Business Overview
11.7.3 Mylan NV Liver Failure Therapeutics Introduction
11.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2016-2021)
11.7.5 Mylan NV Recent Development
11.8 Ocera Therapeutics Inc
11.8.1 Ocera Therapeutics Inc Company Details
11.8.2 Ocera Therapeutics Inc Business Overview
11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
11.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.8.5 Ocera Therapeutics Inc Recent Development
11.9 PledPharma AB
11.9.1 PledPharma AB Company Details
11.9.2 PledPharma AB Business Overview
11.9.3 PledPharma AB Liver Failure Therapeutics Introduction
11.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2016-2021)
11.9.5 PledPharma AB Recent Development
11.10 Promethera Biosciences SA
11.10.1 Promethera Biosciences SA Company Details
11.10.2 Promethera Biosciences SA Business Overview
11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
11.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2016-2021)
11.10.5 Promethera Biosciences SA Recent Development
11.11 Silence Therapeutics Plc
11.11.1 Silence Therapeutics Plc Company Details
11.11.2 Silence Therapeutics Plc Business Overview
11.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
11.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.11.5 Silence Therapeutics Plc Recent Development
11.12 Unicyte AG
11.12.1 Unicyte AG Company Details
11.12.2 Unicyte AG Business Overview
11.12.3 Unicyte AG Liver Failure Therapeutics Introduction
11.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2016-2021)
11.12.5 Unicyte AG Recent Development
11.13 Ventria Bioscience
11.13.1 Ventria Bioscience Company Details
11.13.2 Ventria Bioscience Business Overview
11.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
11.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2016-2021)
11.13.5 Ventria Bioscience Recent Development
11.14 Vital Therapies Inc
11.14.1 Vital Therapies Inc Company Details
11.14.2 Vital Therapies Inc Business Overview
11.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
11.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.14.5 Vital Therapies Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Liver Failure Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ornithine Phenylacetate
Table 3. Key Players of MTL-CEBPA
Table 4. Key Players of F-573
Table 5. Key Players of BL-1220
Table 6. Key Players of PP-100
Table 7. Key Players of Others
Table 8. Global Liver Failure Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Liver Failure Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Liver Failure Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Liver Failure Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Liver Failure Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Liver Failure Therapeutics Market Share by Regions (2022-2027)
Table 14. Liver Failure Therapeutics Market Trends
Table 15. Liver Failure Therapeutics Market Drivers
Table 16. Liver Failure Therapeutics Market Challenges
Table 17. Liver Failure Therapeutics Market Restraints
Table 18. Global Liver Failure Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Liver Failure Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2020)
Table 21. Ranking of Global Top Liver Failure Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Liver Failure Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Liver Failure Therapeutics Product Solution and Service
Table 25. Date of Enter into Liver Failure Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Liver Failure Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Liver Failure Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Liver Failure Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Liver Failure Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Liver Failure Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Liver Failure Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Liver Failure Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Liver Failure Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Liver Failure Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Alfact Innovation Company Details
Table 66. Alfact Innovation Business Overview
Table 67. Alfact Innovation Liver Failure Therapeutics Product
Table 68. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Alfact Innovation Recent Development
Table 70. BioLineRx Ltd Company Details
Table 71. BioLineRx Ltd Business Overview
Table 72. BioLineRx Ltd Liver Failure Therapeutics Product
Table 73. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 74. BioLineRx Ltd Recent Development
Table 75. Cell2B Advanced Therapeutics SA Company Details
Table 76. Cell2B Advanced Therapeutics SA Business Overview
Table 77. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product
Table 78. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Cell2B Advanced Therapeutics SA Recent Development
Table 80. Conatus Pharmaceuticals Inc Company Details
Table 81. Conatus Pharmaceuticals Inc Business Overview
Table 82. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 83. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Conatus Pharmaceuticals Inc Recent Development
Table 85. Immune Pharmaceuticals Inc Company Details
Table 86. Immune Pharmaceuticals Inc Business Overview
Table 87. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 88. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Immune Pharmaceuticals Inc Recent Development
Table 90. Mina Therapeutics Ltd Company Details
Table 91. Mina Therapeutics Ltd Business Overview
Table 92. Mina Therapeutics Ltd Liver Failure Therapeutics Product
Table 93. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Mina Therapeutics Ltd Recent Development
Table 95. Mylan NV Company Details
Table 96. Mylan NV Business Overview
Table 97. Mylan NV Liver Failure Therapeutics Product
Table 98. Mylan NV Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Mylan NV Recent Development
Table 100. Ocera Therapeutics Inc Company Details
Table 101. Ocera Therapeutics Inc Business Overview
Table 102. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Ocera Therapeutics Inc Recent Development
Table 104. PledPharma AB Company Details
Table 105. PledPharma AB Business Overview
Table 106. PledPharma AB Liver Failure Therapeutics Product
Table 107. PledPharma AB Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 108. PledPharma AB Recent Development
Table 109. Promethera Biosciences SA Company Details
Table 110. Promethera Biosciences SA Business Overview
Table 111. Promethera Biosciences SA Liver Failure Therapeutics Product
Table 112. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Promethera Biosciences SA Recent Development
Table 114. Silence Therapeutics Plc Company Details
Table 115. Silence Therapeutics Plc Business Overview
Table 116. Silence Therapeutics Plc Liver Failure Therapeutics Product
Table 117. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Silence Therapeutics Plc Recent Development
Table 119. Unicyte AG Company Details
Table 120. Unicyte AG Business Overview
Table 121. Unicyte AG Liver Failure Therapeutics Product
Table 122. Unicyte AG Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 123. Unicyte AG Recent Development
Table 124. Ventria Bioscience Company Details
Table 125. Ventria Bioscience Business Overview
Table 126. Ventria Bioscience Liver Failure Therapeutics Product
Table 127. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 128. Ventria Bioscience Recent Development
Table 129. Vital Therapies Inc Company Details
Table 130. Vital Therapies Inc Business Overview
Table 131. Vital Therapies Inc Liver Failure Therapeutics Product
Table 132. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 133. Vital Therapies Inc Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Failure Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Ornithine Phenylacetate Features
Figure 3. MTL-CEBPA Features
Figure 4. F-573 Features
Figure 5. BL-1220 Features
Figure 6. PP-100 Features
Figure 7. Others Features
Figure 8. Global Liver Failure Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Liver Failure Therapeutics Report Years Considered
Figure 13. Global Liver Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Liver Failure Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Liver Failure Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Liver Failure Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Liver Failure Therapeutics Market Share by Players in 2020
Figure 18. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2020
Figure 20. Global Liver Failure Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Liver Failure Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Liver Failure Therapeutics Market Share by Region (2016-2027)
Figure 42. China Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 62. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 63. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 64. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 65. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 66. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 67. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 68. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 69. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 70. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 71. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 72. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 73. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 74. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---